Showing results (171-180 of 451) with videos related to
Sort By:
Pageof 46
Expert Opinion on Biological Therapy|July 14, 2009
Multipeptide vaccination in cancer patientsLorenzo Pilla, Licia Rivoltini, Roberto Patuzzo, et al.Tumori|February 29, 1984
Inhibition of human melanoma growth in nude mice by autologous, alloactivated peripheral blood lymphocytesA Balsari, G Fossati, D Taramelli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccinationM Sensi, C Farina, C Maccalli, et al.European Journal of Immunology|November 1, 1982
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigensJ Van Snick, J Maryanski, A Van Pel, et al.International Journal of Cancer|May 29, 1996
Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasisC Cillo, M Cantile, R Mortarini, et al.International Immunology|September 1, 1996
Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigensC Farina, P van der Bruggen, P Boël, et al.Tissue Antigens|July 24, 2002
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clonesM Sensi, S Pellegatta, C Vegetti, et al.Methods in Molecular Medicine|February 11, 2012
Gene therapy in melanomaG Parmiani, F Arienti, C Melani, et al.Melanoma Research|February 1, 1994
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanomaR Lupetti, M Sensi, R Mortarini, et al.Cancer Research|January 1, 1986
Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesionsD Taramelli, G Fossati, A Mazzocchi, et al.Pageof 46